Altimmune (ALT) PT Lowered to $24 at JMP Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
- Unity Software stock soars 22% on strong Q3 beat, robust guidance
Tweet
Share
E-mailGet Alerts ALT Hot Sheet
Price: $2.12 --0%
Rating Summary:
13 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 20 | Down: 36 | New: 6
Rating Summary:
13 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 20 | Down: 36 | New: 6
Join SI Premium – FREE
JMP Securities analyst Jonathan Wolleben lowered the price target on Altimmune (NASDAQ: ALT) to $24.00 (from $25.00) while maintaining a Market Outperform rating.
You May Also Be Interested In
- Altimmune to Report Third Quarter 2026 Financial Results and Provide Business Update on November 12, 2026
- McKesson (MCK) PT Raised to $1,250 at UBS
- Medline Inc (MDLN) PT Raised to $49 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
